Eric Kohlmann has a long and varied work experience. Eric began their career in 2013 as Co-Founder and Board Member of Kohlmann & Co AG, where they invested in numerous technology startups. In the same year, they also became Co-Founder and Advisor of Bloom Diagnostics, a smart diagnostics startup currently in FDA approval process. In 2016, Eric joined Trinnacle Fund Ltd. as a Board of Directors and SQream as an Investor. In 2018, they became an Investor in CTRL-labs, and in 2020 they joined Arc Ventures as a Venture Partner, partnering with a single family office to manage venture capital portfolio and allocations in over 50 VC Funds. Additionally, they are an Investor in Omneky and in 2022 they will become a Board Member and Investor of Sania Therapeutics and Co-Founder and Board Member of Creatives Care (Non-Profit).
Eric Kohlmann completed a Master's Degree in Finance from IE Business School from 2014 to 2015. From 2010 to 2012, they obtained a Bachelor of Science (BSc) in Physics from ETH Zürich/ TU Munich. Eric also studied Physics at ETH Zürich from 2008 to 2011. From 2006 to 2008, they completed an A-Level in Physics (A), Chemistry (A), Design&Technology (A), German (A), Maths (A), and Further Maths (A) at Eton College.
This person is not in the org chart
This person is not in any teams
This person is not in any offices